These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 20977807
1. [High prognostic significance of blood pressure variability in consecutive checks]. van Montfrans GA. Ned Tijdschr Geneeskd; 2010; 154():A2670. PubMed ID: 20977807 [Abstract] [Full Text] [Related]
2. [Retrospective studies and prospects of therapy for hypertension]. Maisch B, Brilla C, Kruse T, Noll B, Bethge C. Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697 [Abstract] [Full Text] [Related]
3. [Visit-to-visit variability: Prognostic significance?]. Ly C, Agnoletti D, Safar M, Blacher J. Presse Med; 2012 Jun; 41(6 Pt 1):650-4. PubMed ID: 22498102 [Abstract] [Full Text] [Related]
4. Blood pressure and coronary heart disease: a review of the evidence. Lawes CM, Bennett DA, Lewington S, Rodgers A. Semin Vasc Med; 2002 Nov; 2(4):355-68. PubMed ID: 16222626 [Abstract] [Full Text] [Related]
5. [Drugs and arterial stiffness in hypertensive patients]. Laurent S. Drugs; 2003 Nov; 63 Spec No 1():1-8. PubMed ID: 12708878 [Abstract] [Full Text] [Related]
6. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B. Blood Press; 2004 Nov; 13(3):137-41. PubMed ID: 15223721 [Abstract] [Full Text] [Related]
7. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138 [Abstract] [Full Text] [Related]
8. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy. Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B. Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679 [Abstract] [Full Text] [Related]
9. [Are all antihypertensive drugs renoprotective?]. Wolf S, Risler T. Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950 [Abstract] [Full Text] [Related]
10. Primary and secondary prevention of stroke by antihypertensive drug treatment. Wang JG, Li Y. Expert Rev Neurother; 2004 Nov; 4(6):1023-31. PubMed ID: 15853529 [Abstract] [Full Text] [Related]
11. Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke. Howard SC, Rothwell PM. Cerebrovasc Dis; 2009 Nov; 28(4):331-40. PubMed ID: 19628934 [Abstract] [Full Text] [Related]
12. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff. Epstein BJ, Anderson S. Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086 [Abstract] [Full Text] [Related]
14. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA. J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [Abstract] [Full Text] [Related]